Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immuno-oncologic signature of malignant transformation in oral squamous cell carcinoma. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2023 | 37739913 | PubTator, text mining | PubMed |
| Stroke-like presentation of acute toxic leukoencephalopathy due to capecitabine treatment with extensive intramyelinic edema. | Chronic Dis Transl Med | 2023 | 37711866 | PubTator, text mining | PubMed |
| Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism. | NPJ Syst Biol Appl | 2023 | 37689794 | PubTator, text mining | PubMed |
| Extracorporeal Membrane Oxygenation (ECMO) for suspected neonatal genetic diagnoses with cardiorespiratory failure. | J Extra Corpor Technol | 2023 | 37682215 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 Meeting. | Dig Dis Sci | 2023 | 37650948 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Molecular and Cellular Advances in Endometriosis Research: Paving the Way for Future Directions. | Int J Mol Sci | 2023 | 37628844 | PubTator, text mining | PubMed |
| Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction. | J Mol Med (Berl) | 2023 | 37603049 | PubTator, text mining | PubMed |
| The Progress of Platelets in Breast Cancer. | Cancer Manag Res | 2023 | 37589033 | PubTator, text mining | PubMed |
| Nuclear genetic control of mtDNA copy number and heteroplasmy in humans. | Nature | 2023 | 37587338 | PubTator, text mining | PubMed |
| A review of FDA approved drugs and their formulations for the treatment of breast cancer. | Front Pharmacol | 2023 | 37576816 | PubTator, text mining | PubMed |
| Exploring the potential of contrast agents in breast cancer echography: current state and future directions. | J Ultrasound | 2023 | 37566194 | PubTator, text mining | PubMed |
| Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Series of Bis-1,2,4-Triazoles as Thymidine Phosphorylase Inhibitor. | Adv Appl Bioinform Chem | 2023 | 37560149 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. | PLoS One | 2023 | 37556419 | PubTator, text mining | PubMed |
| The effect of leukocyte- and platelet-rich fibrin on the bone loss and primary stability of implants placed in posterior maxilla: a randomized clinical trial. | Int J Implant Dent | 2023 | 37555894 | PubTator, text mining | PubMed |
| Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases. | Clin Proteomics | 2023 | 37550624 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer. | World J Gastrointest Oncol | 2023 | 37546563 | PubTator, text mining | PubMed |
| Ocular manifestations of mitochondrial neurogastrointestinal encephalomyopathy: A case report and literature review. | Am J Med Genet A | 2023 | 37530213 | PubTator, text mining | PubMed |
| Role of mitochondrial alterations in human cancer progression and cancer immunity. | J Biomed Sci | 2023 | 37525297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=12